Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Dec 27, 2023
- Accession no.
- 0001447362-23-000192
- Filed
- Dec 27, 2023
- Trade date
- Dec 22-26, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 14 non-derivative transactions. Open-market sales total $260.5K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 22, 2023 | Common Stock | SSaleDisposed | −5,224 | $21.96F2 | −$114,719.04 | 81,294 | Direct | |
| Dec 22, 2023 | Common Stock | SSaleDisposed | −213 | $21.96F2 | −$4,677.48 | 92,786 | Indirect | |
| Dec 22, 2023 | Common Stock | SSaleDisposed | −213 | $21.96F2 | −$4,677.48 | 81,681 | Indirect | |
| Dec 22, 2023 | Common Stock | SSaleDisposed | −76 | $21.96F2 | −$1,668.96 | 11,894 | Indirect | |
| Dec 22, 2023 | Common Stock | SSaleDisposed | −78 | $21.96F2 | −$1,712.88 | 11,890 | Indirect | |
| Dec 22, 2023 | Common Stock | SSaleDisposed | −78 | $21.96F2 | −$1,712.88 | 11,889 | Indirect | |
| Dec 22, 2023 | Common Stock | SSaleDisposed | −78 | $21.96F2 | −$1,712.88 | 11,884 | Indirect | |
| Dec 26, 2023 | Common Stock | SSaleDisposed | −5,180 | $21.93F9 | −$113,597.4 | 76,114 | Direct | |
| Dec 26, 2023 | Common Stock | SSaleDisposed | −211 | $21.93F9 | −$4,627.23 | 92,575 | Indirect | |
| Dec 26, 2023 | Common Stock | SSaleDisposed | −211 | $21.93F9 | −$4,627.23 | 81,470 | Indirect | |
| Dec 26, 2023 | Common Stock | SSaleDisposed | −76 | $21.93F9 | −$1,666.68 | 11,818 | Indirect | |
| Dec 26, 2023 | Common Stock | SSaleDisposed | −77 | $21.93F9 | −$1,688.61 | 11,813 | Indirect | |
| Dec 26, 2023 | Common Stock | SSaleDisposed | −77 | $21.93F9 | −$1,688.61 | 11,812 | Indirect | |
| Dec 26, 2023 | Common Stock | SSaleDisposed | −77 | $21.93F9 | −$1,688.61 | 11,807 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $21.42 to $22.21, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $21.81 to $22.03, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 7 transactions in Table I.